Views & Analysis Inhalation technology: the future of effective respiratory t... Simon Moore discusses non-clinical development channels: technical strategies, formulations and devices.
News Breathing space for GSK as Mylan's Advair copy rejected Stay of execution for ageing blockbuster
News Propeller Health set for expansion with latest funding round $21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
News Novartis pays $1bn upfront for Huntington's drug from PTC Novartis has made a return to the Huntington's disease stage by licensing an oral mRNA splicer from PTC Therapeutics for $1 billion upfront.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
